As reported on the front page of the New York Times Science section, clinical applications of stem cell based therapies are accelerating at a rate that will revolutionize the medical field in a matter of years. In the United States alone, there are currently over 4000 therapies in clinical trials for the treatment of heart disease, blindness, spinal cord injuries, diabetes, H.I.V., and other diseases, injuries, and traumas.
While many of these treatments are still in the early phases of their clinical trials, patients suffering from heart attacks to Alzheimer’s disease are already benefiting from the regenerative abilities of stem cells. Furthermore, researchers have been able recover stem cells from patients with specific ailments to reproduce and study the disease in vitro (in a lab), allowing them to study and develop new therapies for previously difficult to treat diseases such as ALS.
While the report touches on a number of stem cell related topics – including embryonic stem cells and IPSCs, it is interesting to note that the focus of the report is Mr. Edgar Irastorza, a 31 year old Miami property manager, break-dancer and former high school wrestler, who, after suffering a severe heart attack, underwent a stem cell treatment utilizing his own stem cells. Prior to the treatment, Mr. Irastorza’s lifestyle was severely compromised as he was unable to dance or even pick up his kids from school but after the treatment, he is breakdancing again and engaged with his children.
We believe Mr. Irastorza’s experience represents the gold standard of emerging stem cell treatments; that the best stem cells to use will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn more about banking your own valuable stem cells to insure your family’s future health, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.